Kabat rehabilitation for Bell’s palsy in the elderly

2016 ◽  
Vol 137 (6) ◽  
pp. 646-650 ◽  
Author(s):  
Simonetta Monini ◽  
Antonella Buffoni ◽  
Martina Romeo ◽  
Mario Di Traglia ◽  
Chiara Filippi ◽  
...  
Vaccines ◽  
2021 ◽  
Vol 9 (7) ◽  
pp. 746
Author(s):  
Nayoung Jeong ◽  
Yejee Kim ◽  
Chungjong Kim ◽  
Sangmin Park ◽  
Joongyub Lee ◽  
...  

Previous studies have shown controversial results on the risk of Bell’s palsy after influenza vaccination. Since the antigenic components of influenza vaccine can vary from season to season, continuous safety monitoring is required. The aim of the present study was to determine whether there was an increased risk of Bell’s palsy in the elderly after influenza vaccination between the 2015/2016 and 2017/2018 flu seasons. This study included the elderly who received influenza vaccinations for three flu seasons using a large-linked database of vaccination registration data from the Korea Disease Control and Prevention Agency and the National Health Insurance Service claims data. We used a self-controlled risk interval design with a risk interval of 1 to 42 days and a control interval of 57 to 98 days postvaccination and calculated the incidence rate ratio. To ensure the robustness of the results, sensitivity analyses were also carried out with different risk and control intervals. Of 4,653,440 elderly people who received the influenza vaccine, there was no statistically significant increase in the risk of Bell’s palsy (IRR: 0.99, 95% CI: 0.92–1.07). Similar results were found in analysis results for each season and the results of the sensitivity analyses excluding the 2017/2018 season. In conclusion, we found no evidence of an increased risk of Bell’s palsy after influenza vaccination. The results of our study provide reassurance about the safety of the influenza vaccine NIP program. However, it is necessary to continuously monitor the risk of Bell’s palsy during future flu seasons.


1974 ◽  
Vol 7 (2) ◽  
pp. 407-409
Author(s):  
W. Hugh Powers
Keyword(s):  

2012 ◽  
Vol 73 (S 02) ◽  
Author(s):  
L. M. Marques ◽  
J. Pimentel ◽  
P. Escada ◽  
G. Neto D'Almeida

Diabetes ◽  
1975 ◽  
Vol 24 (5) ◽  
pp. 449-451 ◽  
Author(s):  
K. Adour ◽  
J. Wingerd ◽  
H. E. Doty

2019 ◽  
Author(s):  
Myung Chul Yoo ◽  
Yunsoo Soh ◽  
Jinmann Chon ◽  
Jong Ha Lee ◽  
Junyang Jung ◽  
...  

Author(s):  
Lodha Sheetal Ganeshlalji

Ardita is one of the Vata Vyadhi. Management of Ardita is same as Vata Vyadhi. It includes Nasya, Murdhnitala, Basti. Karnapurana and Akshitarpana. Akshitarpana is a unique procedure where medicated ghee is retained over the eyes for a specific amount of time. Ardita can be correlated with Bell’s palsy. Symptoms like incomplete closure of eye, watering of eye, deviation of mouth, forehead creases loss, earache, dribbling of saliva, heaviness of face, taste loss, hyperacusis are same. In this study efficacy of Akshitarpan is evaluated in Ardita. Triphala Ghruta is selected to do Akshitarpan. Subjective criteria for assessment are watering of eye, deviation of mouth, forehead creases loss, earache, dribbling of saliva, heaviness of face, taste loss, hyperacusis. Total 30 patients were taken for study. Objective criteria for assessment is incomplete closure of eye. Accurate tests are applied to data. Study reveals that Triphala Ghruta Akshitarpana has effect on only 2 symptoms of Ardita. i.e. Incomplete closure of eye and watering of eye.


2014 ◽  
Vol 4 (5) ◽  
Author(s):  
Mohammed Ather ◽  
, Nasreen ◽  
K V Neelima
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document